Skip to main content
. 2012 Mar;14(3):206–218. doi: 10.1593/neo.111758

Table 3.

Most Frequent Microalterations Involving Single Genes in 15 Cortisol-Secreting ACAs According to CNAs Detected by High-resolution SNP Arrays.

Cytoband n (%) CNA CN Score Gene Description
12q12 3 (20) Gain 5.23 Contained within C12orf40 Chromosome 12 open reading frame 40
6q16.1 3 (20) Gain 4.33 Contained within EPHA7 Ephrin receptor 7
9q34.3 3 (20) Gain 3.64 Overlap with 51% of FAM157B Family with sequence similarity 157, member B
2q11.2 2 (13) Gain 4.71 Intron of C2orf55 Chromosome 2 open reading frame 55
Xq22.3 2 (13) Gain 4.60 Contained within IL1RAPL2 Interleukin 1 receptor accessory protein-like 2
11q14.1 2 (13) Gain 4.57 Intron of DLG2 Discs large homolog 2
12q21.31 2 (13) Gain 4.51 Intron of MGAT4C Mannosyl-glycoprotein β-1,4-N-acetylglucosaminyltransferase, isozyme C
2q24.3 2 (13) Gain 4.36 Contained within SCN9A Sodium channel, voltage-gated, type IX, α subunit
12q21.32 2 (13) Gain 4.27 Intron of KITLG KIT ligand
14q21.3 2 (13) Gain 4.26 Contained within MDGA2 MAM domain containing glycosylphosphatidylinositol anchor 2
12q13.3 2 (13) Gain 4.02 TAC3 Tachykinin 3
4p15.31 2 (13) Gain 4.00 Intron of KCNIP4 Kv channel interacting protein 4
3p14.2 2 (13) Gain 3.95 Intron of FHIT Fragile histidine triad gene
10q11.21 2 (13) Gain 3.92 Overlap with 54% of ZNF33B Zinc finger protein 33B
10p11.21 2 (13) Gain 3.91 Contained within ANKRD30A Ankyrin repeat domain 30A
2p12 2 (13) Gain 3.85 Intron of LRRTM4 Leucine-rich repeat transmembrane neuronal 4
10q21.1 2 (13) Gain 3.81 Intron of PRKG1 Protein kinase, cGMP-dependent, type I
13q14.2 2 (13) Gain 3.79 Intron of CAB39L Calcium binding protein 39-like
1q44 2 (13) Gain 3.68 Intron of KIF26B Kinesin family member 26B
18q12.3 2 (13) Gain 3.49 Intron of RIT2 Ras-like without CAAX 2
11p11.12 2 (13) Gain 3.34 OR4A5 Olfactory receptor family 4 subfamily A member 5
7p13 2 (13) Gain 3.10 Contained within CAMK2B Calcium/calmodulin-dependent protein kinase II β
Xq28 2 (13) Gain 2.91 Overlap with 88% of IDH3G Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial precursor
Xq28 2 (13) Gain 2.83 Intron of F8 Coagulation factor VIII precursor
7p22.2 2 (13) Gain 2.73 Intron of GNA12 G protein alpha 12
8q24.3 2 (13) Gain 2.64 CYP11B1 Cytochrome P450 11B1, mitochondrial precursor
8q24.3 2 (13) Gain 2.64 C8orf33 Chromosome 8 open reading frame 33
5p15.33 2 (13) Gain 2.61 IRX4 Iroquois homeobox 4
6q23.2 2 (13) Loss 0.84 Contained within SGK1 Serum/glucocorticoid-regulated kinase 1
2q11.2 2 (13) Loss 0.88 Intron of NPAS2 Neuronal PAS domain protein 2
3p22.1 2 (13) Loss 0.96 Contained within CTNNB1 Catenin (cadherin-associated protein), β 1
6q22.31 2 (13) Loss 1.00 HEY2 Hairy/enhancer-of-split related with YRPW motif 2
6q26 2 (13) Loss 1.01 Contained within QKI Quackin protein
18q11.2 2 (13) Loss 1.10 Contained within LAMA3 Laminin subunit alpha-3 precursor
6q21 2 (13) Loss 1.02 Overlap with 70% of REV3L DNA polymerase zeta catalytic subunit
2p16.2-.1 2 (13) Loss 1.03 Overlap with 50% of EML6 Echinoderm microtubule-associated protein like 6
1q23.1 2 (13) Loss 1.12 CD5L CD5 antigen-like precursor
6q23.3 2 (13) Loss 1.13 Contained within KIAA1244
1p36.11 2 (13) Loss 1.16 Overlap with 60% of TMEM57 Macoilin (transmembrane protein 57)
11q23.2 2 (13) Loss 1.16 FAM55D Family with sequence similarity 55, member D
18q12.2 2 (13) Loss 1.18 Intron of FHOD3 FH1/FH2 domain-containing protein 3
6q23.1 2 (13) Loss 1.29 Contained within EPB41L2 Erythrocyte membrane band 4.1-like protein 2
6q25.2 2 (13) Loss 1.31 Overlap with 81% of RGS17 Regulator of G protein signaling 17
1p33 2 (13) Loss 1.34 STIL SCL-interrupting locus protein
6q26 2 (13) Loss 1.35 Intron of PACRG PARK2 coregulated
6q25.1-.2 2 (13) Loss 1.36 Overlap with 80% of SYNE1 Synaptic nuclear envelope protein 1

Only CNAs involving one entire gene or contained within one gene or overlapping with more than 50% of one gene are reported.

Genes in bold: genes considered relevant for tumorigenesis or glucocorticoid production/effects. They include potential oncogenes and tumor suppressor genes, growth or transcription factors, cell differentiation markers, protein kinases (according to GSEA; see also Table W4), genes involved in steroidogenesis (underlined) or glucocorticoid regulation or in Wnt/β-catenin signaling.